Fastrain Co., Ltd. (CEO Seungwoo Son), operator of the skin treatment information and reservation platform "Goddess Ticket," announced on the 8th that it has successfully secured 10 billion won in Series C funding. This investment brings Fastrain's cumulative institutional investment to 26.3 billion won.
This Series C round, a pre-IPO investment round, saw participation from seven institutions: the Korea Development Bank, T Investment, Comes Investment, IM Investment Partners, AFW Partners, Mobidic Asset Management, and Hillspring Investment. The investors reportedly positively evaluated Shinsegae Ticket's market growth potential, user base, and platform operational capabilities.
With this investment, Fastlane is preparing for a KOSDAQ listing. CEO Seungwoo Son stated, "We are restructuring our internal organization and expanding our business portfolio, aiming for an IPO in the first half of 2027." He added, "We will further strengthen our platform competitiveness through global expansion and expanded service areas."
Since its launch in 2017, "Goddess Ticket," operated by Fastlane, has established itself as a platform providing information on dermatological and cosmetic procedures. It provides information, prices, and reviews for approximately 27,000 dermatological procedures nationwide, and offers a comparison- and selection-based reservation service for users. As of the first half of this year, Goddess Ticket had approximately 3.6 million cumulative downloads, 850,000 cumulative members, and approximately 530,000 monthly active users (MAU).
The company is also actively pursuing overseas markets. Fastlane recently launched a global version of its Goddess Ticket app in China, the United States, and Japan, targeting international customers. As of the first half of the year, its overseas monthly active users reached approximately 40,000, a 173.4% increase year-on-year.
Meanwhile, based on its experience operating a dermatology-focused platform, Fastlane is pursuing a variety of new initiatives, including expanding its clinical offerings and sales areas, partnering with travel and lodging companies, and launching the "Skin Research Lab," an AI-based skin diagnostic service. Through these initiatives, Fastlane is also actively expanding into the digital healthcare sector.
- See more related articles
You must be logged in to post a comment.